RECBIO-B

02179
3.9000.00% ( 0.000 )
Delay Closed: Nov 17, 16:08:15

Shareholders

All Shareholders

Shareholder Type

  • Private companies31.60%
  • Public and others17.06%
  • Institutions16.66%
  • ESOPs13.74%
  • Others20.94%

Major Shareholders

Major Shareholders Latest
Shareholder
Yangtze River Pharmaceutical Group Co. Ltd
23.20%143.11M0.00%+0
Taizhou Yuangong Technology Partnership (Limited Partnership)
13.43%82.86M0.00%+0
Lhasa Junqi Enterprise Management Co., Ltd.
6.79%41.86M0.00%+0
Taizhou Chaorui Medical Technology Partnership (Limited Partnership)
6.06%37.39M0.00%+0
Hongyan Liu
5.68%35.04M0.00%+0
Lyfe Capital
5.59%34.50M2.94%+18.15M
Shenzhen Qianhai Woying Investment Management Co., Ltd
4.41%27.20M0.00%+0
Jiangsu Zhaoyin Industry Fund Management Co., Ltd.
4.11%25.37M0.40%+2.46M
Shenzhen Oriental Fortune Venture Capital Management Co., Ltd.
2.64%16.30M0.38%+2.33M
Shenzhen Fuhai Xinwan Equity Investment Fund Management Enterprise (L.P.)
2.56%15.77M0.00%+0
Yangtze River (Hong Kong) Limited
2.05%12.62M0.00%+0
Yong LiuFounder, Executive Director & GM
1.99%12.29M--+12.29M
Sequoia Capital Operations LLC
1.45%8.96M0.00%+0
Legend Capital Management Co., Ltd.
0.96%5.92M0.00%+0
Haoyu XuNon-Executive Chairman
0.64%3.96M0.17%-1.07M
Shenzhen Oriental Fortune Capital Co., Ltd.
0.31%1.91M0.15%+923.08K
Taizhou Baibei Biology Technology Partnership (Limited Partnership)
0.25%1.53M0.00%+0
Shenzhen Qianhai Kekong Hong Kong-Shenzhen Venture Capital Co., Ltd.
0.21%1.32M0.05%+330.43K
Jiayi Zhao
0.21%1.28M0.00%+0
Taizhou Xinchuan Law Firm (Limited Partnership)
0.17%1.07M0.00%+0